Is this you?
Request access for Southern Clinical Research using your company work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Intera lens
ICP 5Lift (cardio sample) 0.12Recruit soph 0
Quality Scorecard (1–100)
Overall83Recruit56Ops87Sponsor99Ther95
Performance (observed)
Historical trials
786
Completed
407
Terminated/Withdrawn
99
Completion rate
80%
Active now
262
Phase 2
259
Phase 3
423
Realized enrollment
537,551
First study year
1994
Years active
32
Match confidence
high
Enrollment velocity (inf)
16,798
Therapeutic
Areas
Per ClinicalTrials.gov recruiting profile
Breadth (conditions)
1,253
States
Florida, Louisiana
Recruitment (web observed)
Capability notes
3 active recruiting trials (CT.gov)
Relationships
Sponsors
National Cancer Institute (NCI); Pfizer; Eli Lilly and Company; AbbVie; Merck Sharp & Dohme LLC; Hoffmann-La Roche
CROs
Clinipace Worldwide; Covance; ICON Clinical Research; IQVIA Pty Ltd; Laboratorios Liconsa; Medpace, Inc.
Owner / parent
Unknown
Capacity & people
Investigators
—
Coordinators
—
Tech & DCT
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
Surfaced via ClinicalTrials.gov multi-therapeutic mining. 3 active recruiting trials across 2 location(s). Website/leadership not yet verified.
Recommendation features (sample indication)
Ind fit 0.12Liftability 0.12Overall83
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.